Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Hepatocyte growth factor signalling in cancer metastasis

Martin, Tracey Amanda, Mason, Malcolm David and Jiang, Wen Guo 2011. Hepatocyte growth factor signalling in cancer metastasis. Current Signal Transduction Therapy 6 (2) , pp. 180-190. 10.2174/157436211795659991

Full text not available from this repository.


Since their discovery in the late 1980's, Hepatocyte growth factor (HGF) and it's receptor, c-MET, have become the focus of intense scrutiny as regards their role in cancer and metastasis [1, 2]. HGF is now known to be a potent morphogen that can regulate tissue and organ regeneration and modulate cell morphology, it is a motogen that can stimulate cell motility and migration, and is a mitogen able to regulate cell growth and death and is a powerful angiogenic and lymphangiogenic factor [3-5]. The diverse range of functions that can be ascribed to HGF/c-MET is transmitted via a variety of cell signaling pathways. This review will focus on recent work demonstrating the importance of HGF/c-MET in regulating these signaling events, how they are related to cancer metastasis and where they may be targeted for patient intervention.

Item Type: Article
Status: Published
Schools: Medicine
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Uncontrolled Keywords: Cancer; HGF; Metastasis; Signaling; HGF; c-MET; intracellular signalling; Grb2/SOS; Gab1; PI3 kinase; Stat3; Wnt signaling; Rho/Rac; Protein Kinase C; protein tyrosine phosphates; MAPK; mTOR; ERK; Mcl-1; RAS; MEK; LKB1; Cdc42; Mig6; Phospholipase C g-; cRaf; Catenin; Paxillin; FAK
Publisher: Bentham Science Publishers
ISSN: 1574-3624
Last Modified: 05 Sep 2020 01:24

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item